Skip to main content
. 2017 Mar 1;8(16):26845–26857. doi: 10.18632/oncotarget.15839

Figure 2. Association between PD-L1 expression (%+ve) on tumor cells (TC) and clinical parameters in the whole patient cohort, adenocarcinoma (AD) and squamous cell carcinoma (SCC) subgroups in the first, second and third column, respectively.

Figure 2

Each row signifies a clinical parameter.